AstraZeneca, Westborough, Mass., awarded an estimated $40 million in media buying and planning for new indigestion drug Nexium to Zenith Media
, New York. Nexium is the pharmaceutical company's successor to Prilosec. Zenith competed with three other New York shops: Creative Media, SFM Media/ MPG
and Initiative Media North America. "Nexium needed credible strategic planning skills and network horsepower to get quick visibility in the market,'' said an executive close to the review.
Copyright April 2000, Crain Communications Inc.